Aurinia Pharmaceuticals Inc (AUPH)

8.955 -0.10 (-1.05%) USD  |  NASDAQ  |  May 31, 16:00
8.98 +0.02 (+0.28%) After-Hours: 20:00
More

Aurinia Pharmaceuticals News

News

Headline
Wire
Time (ET)
Aurinia Files Form S-8 to Register Shares Underlying Previously Disclosed Inducement Awards for Newly Hired Employees
Yahoo
05/26 17:16
Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) Shift From Loss To Profit
Yahoo
05/23 06:56
Aurinia Announces 2023 Annual General Meeting Results
Yahoo
05/17 12:14
Here's Why Aurinia Pharmaceuticals (AUPH) is a Great Momentum Stock to Buy
Yahoo
05/11 12:00
Aurinia Pharmaceuticals Says Kidney Biopsy Sub-study Show Lupkynis Improving Renal Response in Lupus Nephritis
MT Newswires
05/09 11:30
News Flash: Analysts Just Made A Sizeable Upgrade To Their Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Forecasts
Yahoo
05/09 06:02
Aurinia Pharmaceuticals Announces Kidney Biopsies Sub-study Data from the LUPKYNIS® (voclosporin) AURORA 2 Clinical Trial Presented at Congress of Clinical Rheumatology East Conference
Yahoo
05/09 06:00
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
Yahoo
05/04 07:15
-- Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Reports Q1 Revenue $34.4M, vs. Street Est of $28.1M
MT Newswires
05/04 06:14
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
Yahoo
05/04 06:00
Aurinia Pharma Q1 2023 Earnings Preview
SA Breaking News
05/03 15:01
Aurinia Pharmaceuticals Announces NICE Recommendation of LUPKYNIS® (Voclosporin) For Adults with Active Lupus Nephritis
Yahoo
05/03 07:51
ISS Joins Glass Lewis in Recommending Aurinia Shareholders Vote "FOR" ALL Company Director Nominees at 2023 Annual General Meeting
Yahoo
05/02 16:36
Aurinia Pharmaceuticals Announces Swissmedic Approval of LUPKYNIS® (voclosporin)
Yahoo
05/02 12:00
--RBC Boosts Price Target on Aurinia Pharmaceuticals to $13 From $11 Ahead of Q1 Report, Keeps Outperform, Speculative Risk
MT Newswires
05/02 07:02
Glass Lewis Recommends Aurinia Shareholders Vote "FOR" ALL Company Director Nominees at 2023 Annual Meeting
Yahoo
04/28 06:30
3 Biotechs That Might Get Bought Out in 2023
Yahoo
04/26 11:30
Toni Braxton and Aurinia Want People with Lupus Nephritis to Get Uncomfortable to Protect their Kidneys
Yahoo
04/25 11:00
Is Aurinia Pharmaceuticals Up for Grabs? Shareholder Suggests a Quick Sale for a Bigger Payday
Yahoo
04/24 17:10
Sector Update: Health Care Stocks Rising Late Monday Afternoon
MT Newswires
04/24 15:57
Sector Update: Health Care Stocks Rising in Afternoon Trading
MT Newswires
04/24 14:05
Aurinia Pharmaceuticals Shareholder MKT Urges Exploration of Company Sale, Plans to Withhold Support for Three Directors
MT Newswires
04/24 12:36
Aurinia Pharma shareholder says company should put itself up for sale
SA Breaking News
04/24 12:18
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023
Yahoo
04/24 06:00
Aurinia (AUPH) Up 11% on Issue of New Additional Lupkynis Patent
Yahoo
04/12 12:34
Why Aurinia Pharmaceuticals Stock Is Glowing Green Today
Yahoo
04/11 14:41
Aurinia Pharmaceutical Says US Patent and Trademark Office Has Issued New Method of Use Patent for Lupkynis; Shares Rise
MT Newswires
04/11 11:32
Aurinia Pharmaceuticals Announces New and Refined Method of Use Patent for LUPKYNIS® in the Treatment of Lupus Nephritis Issued by United States Patent and Trademark Office
Yahoo
04/11 10:26
3 Stocks That Already Doubled in 2023 and Could Keep Climbing
Yahoo
04/11 05:39
Aurinia Pharmaceuticals' Phase 3 Renal Biopsy Studies Show Reduction in Proteinuria
MT Newswires
04/05 07:45
Aurinia's Lupkynis shows promise in 18-month kidney biopsy data
SA Breaking News
04/05 07:07
Aurinia Pharmaceuticals Announces Promising Topline Data from Renal Biopsy Sub-study of the AURORA Trial
Yahoo
04/05 06:30
We Think Aurinia Pharmaceuticals (NASDAQ:AUPH) Can Easily Afford To Drive Business Growth
Yahoo
04/04 06:42
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo
04/03 16:00
Aurinia (AUPH) Surges 11.0%: Is This an Indication of Further Gains?
Yahoo
03/27 04:52
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call Transcript
Yahoo
03/09 09:17
Independent Chairman of the Board George Milne Just Bought 40% More Shares In Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Yahoo
03/08 05:09
Insider Sell: Aurinia Pharmaceuticals
MT Newswires
03/06 16:31
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo
03/06 16:00
Aurinia Pharmaceuticals' Q4 Loss Narrows, Revenue Grows
MT Newswires
02/28 06:43
-- Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q4 Revenue $28.4M, vs. Street Est of $28.8M
MT Newswires
02/28 06:01
Notable earnings before Tuesday's open
SA Breaking News
02/27 10:32
Earnings week ahead: Salesforce, Target, Broadcom, Lowe’s, and more
SA Breaking News
02/24 12:55
Sector Update: Health Care Stocks Mixed Premarket Wednesday
MT Newswires
01/25 09:15
Sector Update: Health Care
MT Newswires
01/25 08:52
Thinking about buying stock in First Wave BioPharma, GasLog Partners, Canoo, Aurinia Pharmaceuticals, or Rocket Lab USA?
PR Newswire
01/25 08:45
Aurinia Pharmaceuticals Receives US Allowance for Patent Covering Lupus Nephritis Treatment
MT Newswires
01/25 04:09
AUPH, LEGN, and RUSHA are among after hour movers
SA Breaking News
01/24 18:00
Aurinia Pharmaceuticals Estimates $28.4 Million in Q4 Revenue
MT Newswires
01/06 06:23
Aurinia Pharmaceuticals guides Q4 revenue above estimates
SA Breaking News
01/06 06:16
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2022 Net Revenue Results
Business Wire
01/06 06:00
Aurinia Pharmaceuticals gains amid M&A speculation following patent settlement
SA Breaking News
01/04 10:30
Hot Stocks: RIVN hits new low; Chinese stocks rise; AUPH surges on settlement; PBR drops
SA Breaking News
01/03 18:10
Nasdaq, S&P, Dow all retreat as 2023 starts on a negative note
SA Breaking News
01/03 14:07
ONCS, TMBR and TUSK among mid-day movers
SA Breaking News
01/03 13:00
Aurinia Pharmaceuticals Reaches Settlement Agreement on Lupkynis With Sun Pharmaceuticals
MT Newswires
01/03 10:47
ReShape, Scilex top healthcare gainers; Palisade, Kala among losers
SA Breaking News
01/03 10:05
Aurinia shares jump 36% on patent challenge settlement with India's Sun Pharma
SA Breaking News
01/03 09:34
GRPN, AUPH and QRTEA are among after hour movers
SA Breaking News
12/09 17:20
Aurinia's lupus nephritis drug Lupkynis gets approval in UK
SA Breaking News
12/01 05:33
Insider Buy: Aurinia Pharmaceuticals
MT Newswires
11/09 16:37
--HC Wainwright Adjusts Price Target on Aurinia Pharmaceuticals to $14 From $26, Maintains Buy Rating
MT Newswires
11/07 09:49
--SVB Securities Adjusts Price Target on Aurinia Pharmaceuticals to $12 From $17, Maintains Outperform Rating
MT Newswires
11/04 11:56
--Oppenheimer Downgrades Aurinia Pharmaceuticals to Perform From Outperform, Notes Continued Commercial Challenges
MT Newswires
11/04 10:35
--RBC Cuts Price Target on Aurinia Pharmaceuticals to $10 From $18, Maintains Outperform, Speculative Risk Rating
MT Newswires
11/04 08:19
HUDI and VAPO among mid-day movers
SA Breaking News
11/03 13:06
Wall Street Set to Open Lower as Investors React to Another Interest Rate Increase
MT Newswires
11/03 09:22
QUALCOMM, Nutrien, Moderna among premarket losers' pack
SA Breaking News
11/03 09:08
US Futures Lower Following Rate Hike, Ahead of Jobless, PMI Data
MT Newswires
11/03 08:11
Top Premarket Decliners
MT Newswires
11/03 08:06
-- Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q3 Revenue $55.8M, vs. Street Est of $36.4M
MT Newswires
11/03 06:09
-- Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q3 Loss $-0.06, vs. Street Est of $-0.19
MT Newswires
11/03 06:09
Aurinia announces resignations of medical chief and senior research executive
SA Breaking News
10/21 06:39
Aurinia adds 12% on rising volume
SA Breaking News
10/20 15:40
Aurinia Pharmaceuticals Secures European Marketing Authorization for Lupkynis
MT Newswires
09/19 11:38
--HC Wainwright Adjusts Aurinia Pharmaceuticals' Price Target to $26 from $30, Keeps Buy Rating
MT Newswires
08/09 08:49
--SVB Financial Adjusts Aurinia Pharmaceuticals Price Target to $17 From $22, Maintains Outperform Rating
MT Newswires
08/08 12:43
--Oppenheimer Adjusts Price Target on Aurinia Pharmaceuticals to $13 From $15, Maintains Outperform Rating
MT Newswires
08/05 09:26
--RBC Cuts Price Target on Aurinia Pharmaceuticals to $18 From $22, Citing Potential Scenarios for '036 Patent; Outperform, Speculative Risk Kept
MT Newswires
08/05 07:50
Catalyst watch: Change Health/UNH DOJ court starts, PayPal earnings , unemployment data
SA Breaking News
07/29 15:43
AUPH, SBFM and AYLA among pre market losers
SA Breaking News
07/27 08:37
Patent challenge on Aurinia's Lupkynis could impact takeover interest near-term - Cantor
SA Breaking News
07/26 11:50
Sector Update: Health Care Stocks Edge Higher Premarket Friday
MT Newswires
07/22 09:21
Aurinia Gets Positive CHMP Opinion for Active Lupus Nephritis Treatment
MT Newswires
07/22 06:22
AUPH, CVM and MGTA among mid-day movers
SA Breaking News
07/15 12:30
Update: Aurinia Pharmaceuticals Names New Chief Commercial Officer As Colao Leaving; Shares Sink
MT Newswires
07/15 11:16
Aurinia Pharma tumbles after takeover speculation cools on new exec hires, exec departure
SA Breaking News
07/15 10:31
NexImmune, Allogene top healthcare gainers; Codexis, 10x Genomics lead losers' pack
SA Breaking News
07/15 10:00
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
MT Newswires
07/15 09:05
Aurinia Pharmaceuticals' Chief Commercial Officer Max Colao to Leave on July 22
MT Newswires
07/15 06:52
Aurinia Pharmaceuticals Appoints Scott Habig Chief Commercial Officer
MT Newswires
07/14 16:39
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $250,000 to Contact the Firm
PR Newswire
06/14 11:00
Final Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Reminds Aurinia Pharmaceuticals Inc. (AUPH) Investors of Class Action and Last Few Hours to Actively Participate
Globe Newswire
06/14 10:48
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Shareholders
PR Newswire
06/14 05:45
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline – AUPH
Globe Newswire
06/13 18:25
AUPH FINAL DEADLINE TOMORROW: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important June 14 Deadline in Securities Class Action – AUPH
Globe Newswire
06/13 12:14
Aurinia Pharmaceuticals Investors: Class Action Lawsuit Filed on Behalf of Investors; The Portnoy Law Firm
Globe Newswire
06/13 08:00
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Aurinia Pharmaceuticals Inc. Investors of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
06/13 05:45
AUPH FINAL DEADLINE ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important June 14 Deadline in Securities Class Action - AUPH
PR Newswire
06/10 17:15
AUPH SHAREHOLDER ALERT: Jakubowitz Law Reminds Aurinia Pharmaceuticals Inc. Shareholders of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
06/10 05:45
AUPH LAWSUIT ALERT: Levi & Korsinsky Notifies Aurinia Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR Newswire
06/09 05:45
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline - AUPH
PR Newswire
06/08 21:30
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Twitter, Stronghold, Aurinia, and Lilium and Encourages Investors to Contact the Firm
Globe Newswire
06/08 21:00
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important June 14 Deadline in Securities Class Action – AUPH
Globe Newswire
06/08 16:45
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aurinia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 14, 2022 - (NASDAQ: AUPH)
PR Newswire
06/08 05:45
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Shareholders
PR Newswire
06/07 05:45
Clover Health, Aurinia Pharma among the top 10 health care additions to Russell 3000 Index, Asensus Surgical, Clovis Oncology among top deletions
SA Breaking News
06/06 11:39
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline – AUPH
Globe Newswire
06/04 23:51
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stronghold, Aurinia, Lilium, and Li-Cycle and Encourages Investors to Contact the Firm
Globe Newswire
06/03 21:00
AUPH INVESTOR NOTICE: NATIONALLY RANKED ROSEN LAW FIRM Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AUPH
Globe Newswire
06/03 18:15
AUPH SHAREHOLDER ALERT: Jakubowitz Law Reminds Aurinia Pharmaceuticals Inc. Shareholders of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
06/03 05:45
Aurinia Pharmaceuticals Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
Globe Newswire
06/02 15:50
AUPH LAWSUIT ALERT: Levi & Korsinsky Notifies Aurinia Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR Newswire
06/02 05:45
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aurinia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 14, 2022 - (NASDAQ: AUPH)
PR Newswire
06/01 05:45
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Shareholders
PR Newswire
05/31 13:30
ROSEN, A LEADING AND RANKED FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH
PR Newswire
05/31 12:44
SDIG, AUPH & LILM Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Top Class Action Firm Reminds Shareholders to Actively Participate
Globe Newswire
05/31 12:10
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – AUPH
Globe Newswire
05/30 18:15
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stronghold, Aurinia, Lilium, and Li-Cycle and Encourages Investors to Contact the Firm
Globe Newswire
05/29 21:00
AUPH SHAREHOLDER ALERT: Jakubowitz Law Reminds Aurinia Pharmaceuticals Inc. Shareholders of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
05/27 05:45
AURINIA PHARMACEUTICALS INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Aurinia Pharmaceuticals Inc.
PR Newswire
05/26 09:20
AUPH LAWSUIT ALERT: Levi & Korsinsky Notifies Aurinia Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR Newswire
05/26 05:45
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline – AUPH
Globe Newswire
05/25 16:17
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aurinia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 14, 2022 - (NASDAQ: AUPH)
PR Newswire
05/25 05:45
AUPH INVESTOR NEWS: TOP RANKED ROSEN LAW FIRM Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH
PR Newswire
05/24 18:15
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Shareholders
PR Newswire
05/24 05:45
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Twitter, Stronghold, Aurinia, and Lilium and Encourages Investors to Contact the Firm
Globe Newswire
05/23 21:00
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline - AUPH
PR Newswire
05/23 20:16
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AUPH
Globe Newswire
05/23 17:11
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Aurinia Pharmaceuticals Inc. Investors of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
05/23 05:45
Aurinia Pharmaceuticals Says Kidney Inflammation Treatment Continuation Study Shows Safety, Tolerability
MT Newswires
05/20 13:16
SDIG, AUPH & LILM Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Top Class Action Firm Reminds Shareholders to Actively Participate
Globe Newswire
05/20 12:02
AUPH SHAREHOLDER ALERT: Jakubowitz Law Reminds Aurinia Pharmaceuticals Inc. Shareholders of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
05/20 05:45
AUPH LAWSUIT ALERT: Levi & Korsinsky Notifies Aurinia Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR Newswire
05/19 14:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Twitter, Aurinia, Stronghold, and Lilium and Encourages Investors to Contact the Firm
Globe Newswire
05/18 21:00
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aurinia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 14, 2022 - (NASDAQ: AUPH)
PR Newswire
05/18 05:45
UPCOMING AUPH DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Aurinia Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR Newswire
05/17 23:55
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline – AUPH
Globe Newswire
05/17 17:49
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Shareholders
PR Newswire
05/17 05:45
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Aurinia Pharmaceuticals Inc. Investors of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
05/16 05:45
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - AUPH
PR Newswire
05/15 11:16
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aurinia, Stronghold, Lilium, and Li-Cycle and Encourages Investors to Contact the Firm
Globe Newswire
05/13 21:00
AUPH SHAREHOLDER ALERT: Jakubowitz Law Reminds Aurinia Pharmaceuticals Inc. Shareholders of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
05/13 05:45
AURINIA PHARMACEUTICALS INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Aurinia Pharmaceuticals Inc.
PR Newswire
05/13 04:52
Aurinia Pharmaceuticals Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
Globe Newswire
05/12 20:34
SDIG, AUPH & LILM Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm Reminds Shareholders to Actively Participate
Globe Newswire
05/12 11:57
AUPH LAWSUIT ALERT: Levi & Korsinsky Notifies Aurinia Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR Newswire
05/12 05:45
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline - AUPH
PR Newswire
05/11 19:27
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aurinia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 14, 2022 - (NASDAQ: AUPH)
PR Newswire
05/11 05:45
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AUPH
Globe Newswire
05/10 19:15
Aurinia Pharmaceuticals Q1 Net Loss Narrows as Revenue Rises; Maintains 2022 Revenue Guidance
MT Newswires
05/10 06:28
-- Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q1 Revenue $21.6M, vs. Street Est of $19.2M
MT Newswires
05/10 06:05
-- Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q1 Loss $-0.27, vs. Street Est of $-0.27
MT Newswires
05/10 06:05
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Shareholders
PR Newswire
05/10 05:45
ROSEN, A LEADING LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH
PR Newswire
05/09 10:26
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Aurinia Pharmaceuticals Inc. Investors of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
05/09 05:45
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Playstudios, Twitter, Aurinia, and Stronghold and Encourages Investors to Contact the Firm
Globe Newswire
05/08 21:00
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline – AUPH
Globe Newswire
05/06 17:36
AURINIA PHARMACEUTICALS INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Aurinia Pharmaceuticals Inc.
PR Newswire
05/06 12:22
AUPH SHAREHOLDER ALERT: Jakubowitz Law Reminds Aurinia Pharmaceuticals Inc. Shareholders of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
05/06 05:45
--Cantor Fitzgerald Assumes Aurinia Pharmaceuticals at Overweight with $25 Price Target
MT Newswires
05/05 13:01
--HC Wainwright Adjusts Price Target on Aurinia Pharmaceuticals to $30 From $33, Reiterates Buy Rating
MT Newswires
05/05 06:14
AUPH LAWSUIT ALERT: Levi & Korsinsky Notifies Aurinia Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR Newswire
05/05 05:45
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – AUPH
Globe Newswire
05/04 16:40
Aurinia Pharmaceuticals Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
Globe Newswire
05/04 07:23
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aurinia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 14, 2022 - (NASDAQ: AUPH)
PR Newswire
05/04 05:45
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Shareholders
PR Newswire
05/03 05:45
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline - AUPH
PR Newswire
05/03 00:35
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Playstudios, Twitter, Aurinia, and Stronghold and Encourages Investors to Contact the Firm
Globe Newswire
05/02 21:00
Aurinia Pharmaceuticals Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Aurinia Pharmaceuticals Inc.
PR Newswire
05/02 20:55
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Aurinia Pharmaceuticals Inc. Investors of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
05/02 05:45
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AUPH
Globe Newswire
04/30 19:15
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH
PR Newswire
04/29 20:15
AUPH SHAREHOLDER ALERT: Jakubowitz Law Reminds Aurinia Pharmaceuticals Inc. Shareholders of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
04/29 05:45
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline – AUPH
Globe Newswire
04/28 13:24
Aurinia price target lowered at RBC citing COVID impact on revenue
SA Breaking News
04/28 11:07
--RBC Cuts Price Target on Aurinia Pharmaceuticals to $22 From $27, Maintains Outperform Rating, Speculative Risk Qualifier
MT Newswires
04/28 08:02
AUPH LAWSUIT ALERT: Levi & Korsinsky Notifies Aurinia Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR Newswire
04/28 05:45
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aurinia, Stronghold, and Lilium and Encourages Investors to Contact the Firm
Globe Newswire
04/27 21:00
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aurinia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 14, 2022 - (NASDAQ: AUPH)
PR Newswire
04/27 05:45
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Shareholders
PR Newswire
04/26 05:45
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Aurinia Pharmaceuticals Inc. Investors of a Lead Plaintiff Deadline of June 14, 2022
PR Newswire
04/25 05:45
INVESTOR ALERT: Aurinia Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - AUPH
PR Newswire
04/23 18:05
AUPH INVESTOR NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AUPH
Globe Newswire
04/23 16:15
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline - AUPH
PR Newswire
04/23 15:46
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aurinia and Playstudios and Encourages Investors to Contact the Firm
Globe Newswire
04/22 21:00
Aurinia Shareholder Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against Aurinia Pharmaceuticals Inc. (AUPH)
Globe Newswire
04/22 18:03
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AUPH
PR Newswire
04/21 15:16
AUPH LAWSUIT ALERT: Levi & Korsinsky Notifies Aurinia Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR Newswire
04/21 05:45
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aurinia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 14, 2022 - (NASDAQ: AUPH)
PR Newswire
04/20 05:45
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Aurinia Pharmaceuticals Inc. (AUPH)
Globe Newswire
04/19 17:38
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AUPH
Globe Newswire
04/19 15:15
Bronstein, Gewirtz & Grossman, LLC Notifies Aurinia Pharmaceuticals Inc. (AUPH) Investors of Class Action and Encourages Investors to Contact the Firm
PR Newswire
04/19 10:00
ALERT: Aurinia Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - AUPH
PR Newswire
04/18 19:27
Pomerantz Law Firm Announces the Filing of a Class Action Against Aurinia Pharmaceuticals Inc., and Certain Officers – AUPH
Globe Newswire
04/15 19:27
AUPH INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation - AUPH
PR Newswire
03/27 11:15
AUPH INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Inquire About Securities Class Action Investigation – AUPH
Globe Newswire
03/24 17:53
ROSEN, A LEADING LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors With Losses to Inquire About Securities Class Action Investigation – AUPH
Globe Newswire
03/18 13:00
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - AUPH
PR Newswire
03/15 18:39
AUPH EQUITY ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Inquire About Securities Class Action Investigation – AUPH
Globe Newswire
03/12 13:00
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurinia Pharmaceuticals Inc. - AUPH
PR Newswire
03/09 19:20
Aurinia gains the most in three months on above average volume
SA Breaking News
03/09 14:19
SVB Leerink Adjusts Aurinia Pharmaceuticals' Price Target to $22 from $30, Keeps Outperform Rating
MT Newswires
03/08 08:41
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurinia Pharmaceuticals Inc. - AUPH
Globe Newswire
03/04 23:11
Insider Sell: Aurinia Pharmaceuticals
MT Newswires
03/04 16:19
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurinia Pharmaceuticals Inc. - AUPH
PR Newswire
03/02 22:00
Aurinia extends losses as analysts cut price targets after Q4 results
SA Breaking News
03/02 13:10
--Oppenheimer Adjusts Aurinia Pharmaceuticals Price Target to $18 From $31, Maintains Outperform Rating
MT Newswires
03/02 10:45
RBC Cuts Price Target on Aurinia Pharmaceuticals to $27 From $31, Maintains Outperform Rating With Speculative Risk Qualifier
MT Newswires
03/01 07:18
Top Midday Decliners
MT Newswires
02/28 13:23
EVBG, IRNT and NTRB among mid-day movers
SA Breaking News
02/28 12:37
Thinking about buying stock in BP, Zomedica, Nio, VEON, or Aurinia Pharmaceuticals?
PR Newswire
02/28 11:05
Wall Street Set for Downbeat Session, Russia-Ukraine Talks in Focus
MT Newswires
02/28 09:20
Sector Update: Health Care Stocks Down In Monday's Premarket Activity
MT Newswires
02/28 09:16
Sector Update: Health Care
MT Newswires
02/28 08:58
Aurinia falls after lower-than-expected sales outlook for 2022
SA Breaking News
02/28 08:08
Top Premarket Decliners
MT Newswires
02/28 08:03
Aurinia Pharmaceuticals Q4 Net Loss Widens as Revenue Falls; Issues 2022 Revenue Outlook
MT Newswires
02/28 06:11
-- Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Reports Q4 Loss $-0.25, vs. Street Est of $-0.27
MT Newswires
02/28 06:03
-- Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q4 Revenue $23.4M, vs. Street Est of $21.8M
MT Newswires
02/28 06:03
Aurinia Pharma Q4 2021 Earnings Preview
SA Breaking News
02/25 12:00
Aurinia Pharma's 2022 Product Revenue Likely to Take Hit from Omicron Spread, RBC Says
MT Newswires
02/23 13:16
--RBC Cuts Price Target on Aurinia Pharmaceuticals to $31 From $34, Maintains Outperform-Speculative Risk Rating
MT Newswires
02/23 08:08
Aurinia Pharma gains after CEO comments on sales outlook
SA Breaking News
02/16 11:35
Will Biogen Q4 earnings bring positive surprise amid Aduhelm woes?
SA Breaking News
02/02 11:37
Aurinia Pharmaceuticals quick uptick on renewed takeover speculation on Biogen news
SA Breaking News
01/28 10:27
Aurinia Pharmaceuticals reverses decline after report on potential M&A interest
SA Breaking News
01/13 14:49
Biogen rebounds amid comments on M&A prospects
SA Breaking News
01/13 14:27
Aurinia Pharmaceuticals drops amid silence on M&A after conference presentations
SA Breaking News
01/13 12:57
Catalyst watch for next week: Biogen, Five Below, Tritium and Monster Beverage in the spotlight
SA Breaking News
01/07 14:00
ICE Biotech index rejig: AUPH, AVXL among added; AMRS, GH among deleted
SA Breaking News
12/17 11:54
Oppenheimer Upgrades Aurinia Pharmaceuticals to Outperform From Perform, Adjusts PT to $31 From $33
MT Newswires
12/10 11:20
Aurinia Pharma upgraded at Oppenheimer; ongoing M&A story noted
SA Breaking News
12/10 08:23
Aurinia Pharmaceuticals nearing highs on report about M&A process
SA Breaking News
12/09 13:25
Sector Update: Health Care Stocks Lower Ahead of Thursday Open
MT Newswires
12/09 08:59
Thinking about buying stock in Ensysce Biosciences, Siyata Mobile, Evgo, Aurinia Pharmaceuticals, or Hall of Fame Resort & Entertainment?
PR Newswire
12/09 08:30
Aurinia Pharmaceuticals Reports Positive Update on Drug to Treat Active Lupus Nephritis
MT Newswires
12/09 06:45
Bristol is one of the worst performing biopharmas this year. Will 2022 be different?
SA Breaking News
12/04 16:00
Hot Stocks: Retail stocks rise; TOL hits high; NRDS sets post-IPO low; AUPH takeover rumor; KIRK plunges
SA Breaking News
12/02 17:49
Correction: Aurinia Pharmaceuticals Stock Rebounds From Wednesday's Decline
MT Newswires
12/02 14:17
Aurinia Pharmaceuticals Stock Rebounds From Tuesday's Decline
MT Newswires
12/02 13:53
Biofrontera, Terns Pharmaceuticals leads healthcare gainers; Context Therapeutics, 180 Life Sciences among major losers
SA Breaking News
12/02 11:03
Moderna, BioNTech among weekly healthcare gainers amid fears over new COVID-19 variant
SA Breaking News
11/27 21:23
Pasithea Therapeutics, Petros Pharmaceuticals leads healthcare gainers; Longeveron, PainReform among major losers
SA Breaking News
11/23 10:57
Hot Stocks: PYPL hits low; oil stocks rise; ASTR reaches orbit; PANW sets high; AUPH plunges
SA Breaking News
11/22 17:44
Sector Update: Health Care Stocks Finishing Mixed This Afternoon
MT Newswires
11/22 16:05
Top Midday Decliners
MT Newswires
11/22 13:57
Sector Update: Health Care Stocks Drifting Near Unchanged Mark Monday
MT Newswires
11/22 13:55
Aurinia Pharmaceuticals Shares Sink After Filing Prospectus to Sell $250 Million Securities
MT Newswires
11/22 13:11
Aurinia falls 28% amid mixed shelf offering, skepticism on buyout rumors
SA Breaking News
11/22 12:43